Document is current
Any future updates will be listed below
-
Authors
Goebeler, Maria-Elisabeth https://orcid.org/0000-0001-5150-3378
Stuhler, Gernot
Bargou, Ralf https://orcid.org/0000-0002-1221-7421
- License Information
-
More Information
Article History
Accepted: 8 May 2024
First Online: 31 May 2024
Competing interests
: M.-E.G. has acted as a consultant and/or adviser to Amgen, AvenCell, Bristol-Myers Squibb, Janssen-Cilag, Novartis and Roche. G.S. holds patents on the hemibody technology and has acted as a consultant to Veraxa Biotech GmbH. R.C.B. has acted as a consultant and/or adviser to Amgen, Avencell, Bristol-Myers Squibb Catalym, Janssen-Cilag, Novartis and Roche, and holds a patent for blinatumomab, from which he receives royalties.
